Today is 2020-9-20, Welcome to the web Shanghai Precision Diagnostics Co.,Ltd Website:

Product introduction

Ovarian Cancer

Font Size: [Big][Mid][Small] 2016-3-23    Views: 478    

Ovarian cancer is the fourth most common malignant tumor among women and causes more deaths than any other type of female reproductive organ cancer. Report from 2012 Cancer Statistics in China showed a total of 49 thousand new breast cancer cases and the projected number of new cases in 2016 is about 69 thousand. Ovarian cancer symptoms are often vague due to the complexity in embryo development, anatomic structure and endocrine function of the ovary. It is very difficult to distinguish an ovarian tumor being benign or malignant before a surgical removal of the tumor. Surface epithelial tumors account for 80-90% of malignant ovarian tumors, of which serous tumors are the most common subtype, followed by malignant germ cell tumors.

Ovarian epithelial cancer patients receiving a surgery were found that the tumor confined to the ovaries was only 30%.  Most of the cancers have spread to the uterus, bilateral attachments, the great retina and pelvic organs. So the early diagnosis is a big challenge.

Our ovarian cancer diagnostic product focuses on serous subtype and is ready for a patent filing.









Contact us